Hypertension in pregnancy (gestational hypertension, suspected pre-eclampsia, chronic hypertension)
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
Severe hypertension or severity sign: emergency
- No tests in the community: refer the same day to the maternity unit (specialist obstetric centre).
- BP ≥ 160/110 mmHg, proteinuria turning positive, severe headache, visual disturbance, epigastric or right hypochondrial bar-like pain, dyspnoea.
Hypertension found after 20 weeks of gestation, without severity signs
Urine tests on a spot sample (not necessarily first morning)
- Urine protein:creatinine ratio
Laboratory tests
- FBC (platelets)
- AST
- ALT
- Serum creatinine
- LDHif neededThrombocytopenia or cytolysis: look for haemolysis, a component of HELLP syndrome (LDH > 600 IU/L, AST or ALT > 2N, platelets < 100 G/L) [2].
- Haptoglobinif neededThrombocytopenia or cytolysis: look for haemolysis, a component of HELLP syndrome (LDH > 600 IU/L, AST or ALT > 2N, platelets < 100 G/L) [2].
Then every week as long as the gestational hypertension lasts
- FBC (platelets)
- AST
- ALT
- Serum creatinine
Do not order
- 24-hour urine protein as a routine, or measurement on the first morning void: NICE recommends the urine protein:creatinine ratio (or albumin:creatinine ratio) on a spot sample [3]
Chronic hypertension (known before pregnancy or before 20 weeks of gestation)
Urine tests (dipstick every month; laboratory if ≥ 1+)
- Urine protein:creatinine ratio
- If pre-eclampsia is suspected: tests from the tab “Hypertension discovered after 20 weeks of gestation” and obstetric opinion.
Laboratory tests in early pregnancy
- FBCif needednon-French guidelineISSHP (2021) has these tests done in every woman with chronic hypertension, from diagnosis during pregnancy, as a baseline in case of later suspected superimposed pre-eclampsia (good practice) [7]. In early pregnancy, the French consensus provides for monitoring BP and testing for proteinuria [1].
- Serum creatinineif needednon-French guidelineISSHP (2021) has these tests done in every woman with chronic hypertension, from diagnosis during pregnancy, as a baseline in case of later suspected superimposed pre-eclampsia (good practice) [7]. In early pregnancy, the French consensus provides for monitoring BP and testing for proteinuria [1].
- ASTif needednon-French guidelineISSHP (2021) has these tests done in every woman with chronic hypertension, from diagnosis during pregnancy, as a baseline in case of later suspected superimposed pre-eclampsia (good practice) [7]. In early pregnancy, the French consensus provides for monitoring BP and testing for proteinuria [1].
- ALTif needednon-French guidelineISSHP (2021) has these tests done in every woman with chronic hypertension, from diagnosis during pregnancy, as a baseline in case of later suspected superimposed pre-eclampsia (good practice) [7]. In early pregnancy, the French consensus provides for monitoring BP and testing for proteinuria [1].
Also consider
- Known chronic hypertension? The tests for chronic hypertension are those of the page “Hypertension”.
After delivery
48 to 72 hours after delivery (pre-eclampsia; often done at the maternity unit)
- FBC (platelets)
- AST
- ALT
- Serum creatinine
Visit 6 to 8 weeks after delivery
- Urine protein:creatinine ratio (or dipstick in the practice)
- Serum creatinine with GFR
- Fasting plasma glucoseif neededAssessment and management of other cardiovascular and renal risk factors, recommended after any hypertension of pregnancy [1].
- Lipid profile (fasting)if neededAssessment and management of other cardiovascular and renal risk factors, recommended after any hypertension of pregnancy [1].
At 3 months if proteinuria persists (≥ 1+)
- Serum creatinine with GFR
- Urine albumin:creatinine ratio
Every year for the first 5 years
- Fasting plasma glucoseif needednon-French guidelineAfter hypertension of pregnancy, the risk of diabetes and hypercholesterolaemia increases: the Netherlands considers these tests every year for 5 years, then every 3 years [11], ISSHP does them at 1 year [7] and SOMANZ considers them every year for 5 to 10 years [4] (expert opinion, no supporting trial). The French consensus asks to assess these risk factors without setting dates [1].
- Lipid profileif needednon-French guidelineAfter hypertension of pregnancy, the risk of diabetes and hypercholesterolaemia increases: the Netherlands considers these tests every year for 5 years, then every 3 years [11], ISSHP does them at 1 year [7] and SOMANZ considers them every year for 5 to 10 years [4] (expert opinion, no supporting trial). The French consensus asks to assess these risk factors without setting dates [1].
- Serum creatinineif needednon-French guidelineAfter hypertension of pregnancy, the risk of diabetes and hypercholesterolaemia increases: the Netherlands considers these tests every year for 5 years, then every 3 years [11], ISSHP does them at 1 year [7] and SOMANZ considers them every year for 5 to 10 years [4] (expert opinion, no supporting trial). The French consensus asks to assess these risk factors without setting dates [1].
- Urine albumin:creatinine ratioif needednon-French guidelineAfter hypertension of pregnancy, the risk of diabetes and hypercholesterolaemia increases: the Netherlands considers these tests every year for 5 years, then every 3 years [11], ISSHP does them at 1 year [7] and SOMANZ considers them every year for 5 to 10 years [4] (expert opinion, no supporting trial). The French consensus asks to assess these risk factors without setting dates [1].
Do not order
- Testing for maternal thrombophilia after pre-eclampsia: not recommended by the CNGOF (strong recommendation) [5].
Sources (11)
- Société française d'hypertension artérielle (SFHTA), en partenariat avec le CNGOF. HTA et grossesse. Consensus d'experts, décembre 2015. Publié : Mounier-Vehier C, Amar J, Boivin JM, et al. Presse Med. 2016;45(7-8 Pt 1):682-99.
- Société française d’anesthésie et de réanimation (SFAR), Collège national des gynécologues et obstétriciens français (CNGOF). Prise en charge de la patiente avec une pré-éclampsie sévère. Recommandations formalisées d’experts communes, 2020 (version publiée : Bonnet MP et al. Anaesth Crit Care Pain Med. 2021;40(5):100901).
- National Institute for Health and Care Excellence (NICE). Hypertension in pregnancy: diagnosis and management. NICE guideline NG133, juin 2019, dernière mise à jour 17 avril 2023.
- Society of Obstetric Medicine of Australia and New Zealand (SOMANZ). Hypertension in Pregnancy Guideline 2023.
- Sentilhes L, Schmitz T, Arthuis C, et al. La prééclampsie : recommandations pour la pratique clinique du Collège national des gynécologues et obstétriciens français (CNGOF). Gynecol Obstet Fertil Senol. 2024;52(1):3-44.
- Agence du numérique en santé. Terminologie LAHN (liste des actes innovants hors nomenclature de biologie et d'anatomopathologie), version 2026-04 : code K301 (Placental Growth Factor).
- Magee LA, Brown MA, Hall DR, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148-169.
- US Preventive Services Task Force, Barry MJ, et al. Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement. JAMA. 2023;330(11):1074-1082.
- Nederlandse Vereniging voor Obstetrie en Gynaecologie (NVOG). Richtlijn Hypertensieve aandoeningen in de zwangerschap, module « Afkapwaarde EKR - pre-eclampsie », 14 juin 2021 (Pays-Bas).
- Lala V, Franzese S. Role of sFlt-1/PlGF Ratio in Diagnosing Preeclampsia. Am Fam Physician. 2024;109(5):470-471.
- Nederlandse Vereniging voor Obstetrie en Gynaecologie (NVOG) et al. Richtlijn CVRM na een reproductieve aandoening, module « Organisatie van zorg bij HAZ », 2 mars 2023 (Pays-Bas).